National Venture Capital Association

Venture capitalists are pouring cash into U.S. biotechs at a rate set to replicate 2018’s record deal count, according to PitchBook and the National Venture Capital Association’s third-quarter Venture Monitor report. In the first three quarters alone, VCs struck 609 biopharma deals...

When the gears of thought push boundaries, a natural story of disruption unfolds. Many eager college graduates looking to start a company have glowing ambitions aimed at a bright future filled only with success. Most end up disappointed when their great idea doesn't pan out, for whatever reason,...